Direkt zum Inhalt
Merck

Currently available drugs for the treatment of obesity: Sibutramine and orlistat.

Mini reviews in medicinal chemistry (2007-02-03)
J-P Chaput, S St-Pierre, A Tremblay
ZUSAMMENFASSUNG

The currently available drugs for long-term treatment of obesity are sibutramine and orlistat. They have been shown to be able to induce significant weight loss, with important co-morbidity reduction, allowing the maintenance of reduced body weight for at least 1-2 years. Cardiostimulating and gastrointestinal adverse effects are however not negligible.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Orlistat, ≥98%, solid
USP
Orlistat, United States Pharmacopeia (USP) Reference Standard